132 related articles for article (PubMed ID: 20450899)
1. Individual and cumulative association of prostate cancer susceptibility variants with clinicopathologic characteristics of the disease.
Bao BY; Pao JB; Lin VC; Huang CN; Chang TY; Lan YH; Lu TL; Lee HZ; Chen LM; Ting WC; Hsieh CJ; Huang SP
Clin Chim Acta; 2010 Sep; 411(17-18):1232-7. PubMed ID: 20450899
[TBL] [Abstract][Full Text] [Related]
2. Prognostic significance of prostate cancer susceptibility variants on prostate-specific antigen recurrence after radical prostatectomy.
Huang SP; Huang LC; Ting WC; Chen LM; Chang TY; Lu TL; Lan YH; Liu CC; Yang WH; Lee HZ; Hsieh CJ; Bao BY
Cancer Epidemiol Biomarkers Prev; 2009 Nov; 18(11):3068-74. PubMed ID: 19900942
[TBL] [Abstract][Full Text] [Related]
3. Tumor characteristics of carriers and noncarriers of the deCODE 8q24 prostate cancer susceptibility alleles.
Helfand BT; Loeb S; Cashy J; Meeks JJ; Thaxton CS; Han M; Catalona WJ
J Urol; 2008 Jun; 179(6):2197-201; discussion 2202. PubMed ID: 18423739
[TBL] [Abstract][Full Text] [Related]
4. Effect of genetic variability within 8q24 on aggressiveness patterns at diagnosis and familial status of prostate cancer.
Cussenot O; Azzouzi AR; Bantsimba-Malanda G; Gaffory C; Mangin P; Cormier L; Fournier G; Valeri A; Jouffe L; Roupret M; Fromont G; Sibony M; Comperat E; Cancel-Tassin G
Clin Cancer Res; 2008 Sep; 14(17):5635-9. PubMed ID: 18765558
[TBL] [Abstract][Full Text] [Related]
5. The rs1447295 at 8q24 is a risk variant for prostate cancer in Taiwanese men.
Chen M; Huang YC; Ko IL; Yang S; Chang YH; Huang WJ; Chen YM
Urology; 2009 Sep; 74(3):698-701. PubMed ID: 19428064
[TBL] [Abstract][Full Text] [Related]
6. Chromosome 8q24 risk variants in hereditary and non-hereditary prostate cancer patients.
Sun J; Lange EM; Isaacs SD; Liu W; Wiley KE; Lange L; Gronberg H; Duggan D; Carpten JD; Walsh PC; Xu J; Chang BL; Isaacs WB; Zheng SL
Prostate; 2008 Apr; 68(5):489-97. PubMed ID: 18213635
[TBL] [Abstract][Full Text] [Related]
7. Clinical significance of tumor necrosis factor receptor superfamily member 11b polymorphism in prostate cancer.
Bao BY; Lin VC; Huang SH; Pao JB; Chang TY; Lu TL; Lan YH; Chen LM; Ting WC; Yang WH; Hsieh CJ; Huang SP
Ann Surg Oncol; 2010 Jun; 17(6):1675-81. PubMed ID: 20204532
[TBL] [Abstract][Full Text] [Related]
8. Correlation of clinical and pathologic factors with rising prostate-specific antigen profiles after radical prostatectomy alone for clinically localized prostate cancer.
Kupelian P; Katcher J; Levin H; Zippe C; Klein E
Urology; 1996 Aug; 48(2):249-60. PubMed ID: 8753737
[TBL] [Abstract][Full Text] [Related]
9. Association of chromosomal locus 8q24 and risk of prostate cancer: a hospital-based study of German patients treated with brachytherapy.
Meyer A; Schürmann P; Ghahremani M; Kocak E; Brinkhaus MJ; Bremer M; Karstens JH; Hagemann J; Machtens S; Dörk T
Urol Oncol; 2009; 27(4):373-6. PubMed ID: 18625567
[TBL] [Abstract][Full Text] [Related]
10. Impact of surgical volume on the rate of lymph node metastases in patients undergoing radical prostatectomy and extended pelvic lymph node dissection for clinically localized prostate cancer.
Briganti A; Capitanio U; Chun FK; Gallina A; Suardi N; Salonia A; Da Pozzo LF; Colombo R; Di Girolamo V; Bertini R; Guazzoni G; Karakiewicz PI; Montorsi F; Rigatti P
Eur Urol; 2008 Oct; 54(4):794-802. PubMed ID: 18514383
[TBL] [Abstract][Full Text] [Related]
11. Association of SNP rs1447295 and microsatellite marker DG8S737 with familial prostate cancer and high grade disease.
Hamano T; Matsui H; Sekine Y; Ohtake N; Nakata S; Suzuki K
J Urol; 2010 Aug; 184(2):738-42. PubMed ID: 20639049
[TBL] [Abstract][Full Text] [Related]
12. Early onset prostate cancer has a significant genetic component.
Lange EM; Salinas CA; Zuhlke KA; Ray AM; Wang Y; Lu Y; Ho LA; Luo J; Cooney KA
Prostate; 2012 Feb; 72(2):147-56. PubMed ID: 21538423
[TBL] [Abstract][Full Text] [Related]
13. Pathological outcomes and biochemical progression in men with T1c prostate cancer undergoing radical prostatectomy with prostate specific antigen 2.6 to 4.0 vs 4.1 to 6.0 ng/ml.
Makarov DV; Humphreys EB; Mangold LA; Walsh PC; Partin AW; Epstein JI; Freedland SJ
J Urol; 2006 Aug; 176(2):554-8. PubMed ID: 16813888
[TBL] [Abstract][Full Text] [Related]
14. Lack of association of prostate carcinoma nuclear grading with prostate specific antigen recurrence after radical prostatectomy.
Zhou M; Hayasaka S; Taylor JM; Shah R; Proverbs-Singh T; Manley S; Rubin MA
J Urol; 2001 Dec; 166(6):2193-7. PubMed ID: 11696734
[TBL] [Abstract][Full Text] [Related]
15. Prognostic factors in lymph node-positive prostate cancer.
Hofer MD; Kuefer R; Huang W; Li H; Bismar TA; Perner S; Hautmann RE; Sanda MG; Gschwend JE; Rubin MA
Urology; 2006 May; 67(5):1016-21. PubMed ID: 16698361
[TBL] [Abstract][Full Text] [Related]
16. Clinical and pathologic outcome after radical prostatectomy for prostate cancer patients with a preoperative Gleason sum of 8 to 10.
Bastian PJ; Gonzalgo ML; Aronson WJ; Terris MK; Kane CJ; Amling CL; Presti JC; Mangold LA; Humphreys E; Epstein JI; Partin AW; Freedland SJ
Cancer; 2006 Sep; 107(6):1265-72. PubMed ID: 16900523
[TBL] [Abstract][Full Text] [Related]
17. Genome-wide scan of brothers: replication and fine mapping of prostate cancer susceptibility and aggressiveness loci.
Witte JS; Suarez BK; Thiel B; Lin J; Yu A; Banerjee TK; Burmester JK; Casey G; Catalona WJ
Prostate; 2003 Dec; 57(4):298-308. PubMed ID: 14601026
[TBL] [Abstract][Full Text] [Related]
18. A genome-wide association screen identifies regions on chromosomes 1q25 and 7p21 as risk loci for sporadic prostate cancer.
Nam RK; Zhang WW; Loblaw DA; Klotz LH; Trachtenberg J; Jewett MA; Stanimirovic A; Davies TO; Toi A; Venkateswaran V; Sugar L; Siminovitch KA; Narod SA
Prostate Cancer Prostatic Dis; 2008; 11(3):241-6. PubMed ID: 17876339
[TBL] [Abstract][Full Text] [Related]
19. Prediction of pelvic lymph node metastasis by the ratio of cathepsin B to stefin A in patients with prostate carcinoma.
Sinha AA; Quast BJ; Wilson MJ; Fernandes ET; Reddy PK; Ewing SL; Gleason DF
Cancer; 2002 Jun; 94(12):3141-9. PubMed ID: 12115346
[TBL] [Abstract][Full Text] [Related]
20. Improved risk stratification for biochemical recurrence after radical prostatectomy using a novel risk group system based on prostate specific antigen density and biopsy Gleason score.
Freedland SJ; Wieder JA; Jack GS; Dorey F; deKernion JB; Aronson WJ
J Urol; 2002 Jul; 168(1):110-5. PubMed ID: 12050502
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]